Skyward Specialty Q2: Operating EPS Jumps 46%, Combined Ratio at 89.5%, Buyback Expanded to $100M
SKWD sits 49% above its 52-week low of $40.6.
Summary
Skyward Specialty posted Q2 2026 diluted operating EPS of $1.30, a 46% year-over-year increase, alongside a combined ratio of 89.5% and 13% premium growth. The share repurchase authorization was also expanded to $100 million.
Key Events · Earnings and Guidance · SKWD
-
Q2 Operating EPS Surges 46%
Diluted operating earnings per share reached $1.30, up from $0.89 a year ago, driven by strong underwriting and investment income.
-
Combined Ratio Improves to 89.5%
The combined ratio was 89.5%, with an ex-cat combined ratio of 87.6%, reflecting disciplined risk selection and expense management.
-
Gross Written Premiums Grow 13%
Gross written premiums rose to $740.6 million, led by a 57.8% increase in Accident & Health and a 95.8% surge in Global Agriculture.
-
Buyback Authorization Doubled to $100M
The company repurchased 223,000 shares for $9.7 million in Q2 and expanded its repurchase program from $50 million to $100 million.
Analysis · SKWD · Finance
A standout second quarter saw diluted operating earnings per share climb 46% to $1.30, fueled by a 13% advance in gross written premiums and underwriting discipline that held the combined ratio to 89.5%. The company also confirmed it repurchased $9.7 million in stock during the quarter and expanded its buyback authorization to $100 million, underscoring confidence in its valuation. With an annualized operating return on equity of 20.4% for the first half and book value per share rising to $28.55, the results highlight Skyward Specialty's capacity to generate top-tier returns in specialty insurance.
At the time of this filing, SKWD was trading at $60.50 on NASDAQ in the Finance sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $40.60 to $63.96. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.